TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway
CONCLUSION: TET3 promoted the DNA demethylation modification in the SHP2 promoter and activated SHP2, thus activating the EGFR/ERK pathway and leading to EC progression.PMID:38456588 | DOI:10.3802/jgo.2024.35.e64 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Fen Xue Lifen Liu Xueqiang Tao Weipei Zhu Source Type: research
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023
J Gynecol Oncol. 2024 Feb 27. doi: 10.3802/jgo.2024.35.e67. Online ahead of print.NO ABSTRACTPMID:38456589 | DOI:10.3802/jgo.2024.35.e67 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Heng-Cheng Hsu Jae-Weon Kim Jeong-Yeol Park Dong Hoon Suh Se Ik Kim Jen-Ruei Chen Peng-Hui Wang Source Type: research
CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma
CONCLUSION: We report that increased CDK1 promotes tumor progression and identified it as a potential prognostic marker and therapeutic target of EMCA.PMID:38456590 | DOI:10.3802/jgo.2024.35.e68 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Xi Lin Yingying He Yiming Liu Huihao Zhou Xiaomin Xu Jingui Xu Kening Zhou Source Type: research
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan
CONCLUSION: Treatment at high-volume centers is the most cost-effective strategy for guiding treatment centralization in patients with endometrial cancer.PMID:38456587 | DOI:10.3802/jgo.2024.35.e61 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Hiroko Machida Koji Matsuo Takahiro Higashi Daisuke Aoki Takayuki Enomoto Aikou Okamoto Hidetaka Katabuchi Satoru Nagase Masaki Mandai Nobuo Yaegashi Wataru Yamagami Mikio Mikami Source Type: research
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway
CONCLUSION: TET3 promoted the DNA demethylation modification in the SHP2 promoter and activated SHP2, thus activating the EGFR/ERK pathway and leading to EC progression.PMID:38456588 | DOI:10.3802/jgo.2024.35.e64 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Fen Xue Lifen Liu Xueqiang Tao Weipei Zhu Source Type: research
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023
J Gynecol Oncol. 2024 Feb 27. doi: 10.3802/jgo.2024.35.e67. Online ahead of print.NO ABSTRACTPMID:38456589 | DOI:10.3802/jgo.2024.35.e67 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Heng-Cheng Hsu Jae-Weon Kim Jeong-Yeol Park Dong Hoon Suh Se Ik Kim Jen-Ruei Chen Peng-Hui Wang Source Type: research
CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma
CONCLUSION: We report that increased CDK1 promotes tumor progression and identified it as a potential prognostic marker and therapeutic target of EMCA.PMID:38456590 | DOI:10.3802/jgo.2024.35.e68 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Xi Lin Yingying He Yiming Liu Huihao Zhou Xiaomin Xu Jingui Xu Kening Zhou Source Type: research
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan
CONCLUSION: Treatment at high-volume centers is the most cost-effective strategy for guiding treatment centralization in patients with endometrial cancer.PMID:38456587 | DOI:10.3802/jgo.2024.35.e61 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Hiroko Machida Koji Matsuo Takahiro Higashi Daisuke Aoki Takayuki Enomoto Aikou Okamoto Hidetaka Katabuchi Satoru Nagase Masaki Mandai Nobuo Yaegashi Wataru Yamagami Mikio Mikami Source Type: research
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway
CONCLUSION: TET3 promoted the DNA demethylation modification in the SHP2 promoter and activated SHP2, thus activating the EGFR/ERK pathway and leading to EC progression.PMID:38456588 | DOI:10.3802/jgo.2024.35.e64 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Fen Xue Lifen Liu Xueqiang Tao Weipei Zhu Source Type: research
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023
J Gynecol Oncol. 2024 Feb 27. doi: 10.3802/jgo.2024.35.e67. Online ahead of print.NO ABSTRACTPMID:38456589 | DOI:10.3802/jgo.2024.35.e67 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Heng-Cheng Hsu Jae-Weon Kim Jeong-Yeol Park Dong Hoon Suh Se Ik Kim Jen-Ruei Chen Peng-Hui Wang Source Type: research
CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma
CONCLUSION: We report that increased CDK1 promotes tumor progression and identified it as a potential prognostic marker and therapeutic target of EMCA.PMID:38456590 | DOI:10.3802/jgo.2024.35.e68 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Xi Lin Yingying He Yiming Liu Huihao Zhou Xiaomin Xu Jingui Xu Kening Zhou Source Type: research
Cost-effectiveness analysis of hospital treatment volume and survival outcomes in endometrial cancer in Japan
CONCLUSION: Treatment at high-volume centers is the most cost-effective strategy for guiding treatment centralization in patients with endometrial cancer.PMID:38456587 | DOI:10.3802/jgo.2024.35.e61 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Hiroko Machida Koji Matsuo Takahiro Higashi Daisuke Aoki Takayuki Enomoto Aikou Okamoto Hidetaka Katabuchi Satoru Nagase Masaki Mandai Nobuo Yaegashi Wataru Yamagami Mikio Mikami Source Type: research
TET3-mediated DNA demethylation modification activates SHP2 expression to promote endometrial cancer progression through the EGFR/ERK pathway
CONCLUSION: TET3 promoted the DNA demethylation modification in the SHP2 promoter and activated SHP2, thus activating the EGFR/ERK pathway and leading to EC progression.PMID:38456588 | DOI:10.3802/jgo.2024.35.e64 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Fen Xue Lifen Liu Xueqiang Tao Weipei Zhu Source Type: research
The 8th Biennial Meeting of the Asian Society of Gynecologic Oncology, December 1st to 3rd, 2023
J Gynecol Oncol. 2024 Feb 27. doi: 10.3802/jgo.2024.35.e67. Online ahead of print.NO ABSTRACTPMID:38456589 | DOI:10.3802/jgo.2024.35.e67 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Heng-Cheng Hsu Jae-Weon Kim Jeong-Yeol Park Dong Hoon Suh Se Ik Kim Jen-Ruei Chen Peng-Hui Wang Source Type: research
CDK1 promotes the phosphorylation of KIFC1 to regulate the tumorgenicity of endometrial carcinoma
CONCLUSION: We report that increased CDK1 promotes tumor progression and identified it as a potential prognostic marker and therapeutic target of EMCA.PMID:38456590 | DOI:10.3802/jgo.2024.35.e68 (Source: Journal of Gynecologic Oncology)
Source: Journal of Gynecologic Oncology - March 8, 2024 Category: OBGYN Authors: Xi Lin Yingying He Yiming Liu Huihao Zhou Xiaomin Xu Jingui Xu Kening Zhou Source Type: research
